3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Adhesions, Tissue in 1 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strowitzki, MJ | 1 |
Ritter, AS | 1 |
Radhakrishnan, P | 1 |
Harnoss, JM | 1 |
Opitz, VM | 1 |
Biller, M | 1 |
Wehrmann, J | 1 |
Keppler, U | 1 |
Scheer, J | 1 |
Wallwiener, M | 1 |
Schmidt, T | 1 |
Ulrich, A | 1 |
Schneider, M | 1 |
1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Adhesions, Tissue
Article | Year |
---|---|
Pharmacological HIF-inhibition attenuates postoperative adhesion formation.
Topics: Animals; Cell Differentiation; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; | 2017 |